SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

ENVB

Enveric Biosciences Inc.
NASDAQHealth Care

Latest close: 1.33 USD · Jul 29, 2026 · 1 year · split-adjusted

On the price, the facts of the public record◆Adverse 8-K filing●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Aug 14, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  2. Aug 14, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Jun 9, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year194
SEC filings on record98115 flagged findings
Reported transactions (Form 4)40since Oct 13, 2021
Corporate events (8-K)30since May 24, 2023

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Listing notice in force

The exchange has notified the company that it fails a continued-listing requirement (8-K, item 3.01 of Oct 23, 2025).

Deadline: Apr 20, 2026 · passed

  • stockholders' equity · Nasdaq, rule 5550(b)(1) · notice of Oct 22, 2025 · pending · deadline Apr 20, 2026 (derived from the rule, not confirmed in the text) · period exhausted with no cure or delisting on record

Open the 8-K at the SEC

Reverse splits in 5 years

3 reverse splits in 5 years (1:50 on Jul 15, 2022, 1:15 on Jan 27, 2025, 1:12 on Oct 28, 2025) · 1:9000 cumulative

The other times: of 215 securities that repeated a reverse split in 5 years, a year later the median was worth 0.10× the price on the day of the split; 167 lost more than half and 20 rose (215 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 981)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Aug 14, 2610-Q ↗Quarterly report
  • Aug 14, 268-K ↗Current report · Results
  • Aug 14, 26SCHEDULE 13G ↗Passive stake · Armistice Capital, LLC · 10.0% · event on Jun 30, 26
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · EASTON JEFF · 1.4% · event on Jun 30, 26 · amendment
  • Aug 13, 26SCHEDULE 13G/A ↗Passive stake · Ayrton Capital LLC · 2.9% · event on Jun 30, 26 · amendment
  • Jun 9, 268-K ↗Current report · Other events
  • Jun 9, 26424B5 ↗Securities offering
  • Jun 9, 268-K ↗Current report · Communication to the market
  • Insider transaction · 8 Form 4 filingsshow all 8hide
  • May 29, 268-K ↗Current report · A senior executive left or was appointed
  • May 15, 2610-Q ↗Quarterly report
  • May 15, 268-K ↗Current report · Results
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · EASTON JEFF · 7.9% · event on Mar 31, 26 · amendment
  • Apr 30, 268-K ↗Current report · Other events
  • Apr 30, 26DEFA14A ↗Shareholder meeting and votes
  • Apr 29, 26424B3 ↗Securities offering
  • Apr 28, 26CORRESP ↗Correspondence with the SEC
  • Apr 27, 26UPLOAD ↗Correspondence with the SEC

981 filings on record, the oldest from May 14, 96.

Listing the 25 most recent filings of the 981 on record.

8-Ks, explained

Stress16Structure128Governance58
  • May 29, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Apr 20, 26StructureSold unregistered shares+3 more in the same filing8-K 3.02 ↗
  • Jan 28, 26StructureSold unregistered shares+2 more in the same filing8-K 3.02 ↗
  • Dec 12, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Oct 23, 25StressListing notice (8-K 3.01)+4 more in the same filing8-K 3.01 ↗
  • Sep 18, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Aug 29, 25StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Apr 14, 25GovernanceAuditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
  • Feb 3, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Nov 22, 24StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Nov 12, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jul 15, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗

12 older filings not shown · The record reaches back to Aug 26, 04.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

The full record holds 16 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Armistice Capital, LLC10.0%Jun 30, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Lind Global Fund III LP10.0%Jan 28, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Braeden Lichti5.0%Dec 3, 25SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Mitchell P. Kopin5.0%Jan 27, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Ayrton Capital LLC2.9%Jun 30, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
show 2 more holdershide
  • AdvisorShares Trust1.7%Dec 31, 25SCHEDULE 13G/A ↗1 earlier filing
  • EASTON JEFF1.4%Jun 30, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Sep 15, 23Buy$2KFRANK PASQUALONE↗
Stock compensation, tax and giftsshow the 39 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Jun 1, 26Compensationamount n/aMICHAEL D WEBB↗
  • Jun 1, 26Compensationamount n/aFRANK PASQUALONE↗
  • Jun 1, 26Compensationamount n/aMarcus Schabacker↗
  • Jun 1, 26Compensationamount n/aGeorge A. Kegler↗
  • Jun 1, 26Compensationamount n/aJoseph Edward TuckerChief Executive Officer↗
  • Jun 1, 26Compensationamount n/aPeter J. FacchiniChief Innovation Officer↗
  • Jun 1, 26Compensationamount n/aKevin Michael CoveneyChief Financial Officer↗
  • Jun 1, 26Compensationamount n/aSheila DeWitt↗
  • Dec 23, 25Compensationamount n/aKevin Michael CoveneyChief Financial Officer↗
  • Dec 23, 25Compensationamount n/aMICHAEL D WEBB↗
  • Dec 23, 25Compensationamount n/aJoseph Edward TuckerChief Executive Officer↗
  • Dec 23, 25Compensationamount n/aMarcus Schabacker↗
  • Dec 23, 25Compensationamount n/aFRANK PASQUALONE↗
  • Dec 23, 25Compensationamount n/aGeorge A. Kegler↗
  • Dec 23, 25Compensationamount n/aSheila DeWitt↗
  • May 8, 25Compensationamount n/aJoseph Edward TuckerCHIEF EXECUTIVE OFFICER↗
  • May 8, 25Compensationamount n/aPeter J. FacchiniCHIEF INNOVATION OFFICER↗
  • May 8, 25Compensationamount n/aKevin Michael CoveneyCHIEF FINANCIAL OFFICER↗
  • Oct 9, 24Compensationamount n/aKevin Michael CoveneyCHIEF FINANCIAL OFFICER↗
  • Oct 9, 24Compensationamount n/aPeter J. FacchiniCHIEF INNOVATION OFFICER↗
  • Oct 9, 24Compensationamount n/aJoseph Edward TuckerCHIEF EXECUTIVE OFFICER↗
  • Oct 9, 24Compensationamount n/aFRANK PASQUALONE↗
  • Oct 9, 24Compensationamount n/aMICHAEL D WEBB↗
  • Oct 9, 24Compensationamount n/aMarcus Schabacker↗
  • Oct 9, 24Compensationamount n/aGeorge A. Kegler↗
  • Oct 9, 24Compensationamount n/aSheila DeWitt↗
  • Feb 22, 24Compensationamount n/aKevin Michael CoveneyCHIEF FINANCIAL OFFICER↗
  • Feb 22, 24Compensationamount n/aPeter J. FacchiniCHIEF INNOVATION OFFICER↗
  • Feb 22, 24Compensationamount n/aJoseph Edward TuckerCHIEF EXECUTIVE OFFICER↗
  • Mar 13, 23Compensationamount n/aKevin Michael CoveneyChief Financial Officer↗
  • Jan 25, 23Compensationamount n/aJoseph Edward TuckerChief Executive Officer↗
  • Jan 25, 23Compensationamount n/aAvani KanubaddiPresident and COO↗
  • Jan 25, 23Compensationamount n/aJillian Marie HagelVice President of Innovation↗
  • Jan 25, 23Compensationamount n/aPeter J. FacchiniChief Innovation Officer↗
  • Oct 13, 21Compensationamount n/aJillian Marie HagelChief Technology Officer↗
  • Oct 13, 21Compensationamount n/aJillian Marie HagelChief Technology Officer↗
  • Oct 13, 21Compensationamount n/aPeter J. FacchiniChief Scientific Officer↗
  • Oct 13, 21Compensationamount n/aPeter J. FacchiniChief Scientific Officer↗
  • Oct 13, 21Compensationamount n/aJoseph Edward TuckerChief Executive Officer↗

The full record holds 41 transactions and goes back to Oct 13, 21.

Its sector and its market

Enveric Biosciences Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Enveric Biosciences Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Enveric Biosciences Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
981 documents on file, from May 14, 1996 to Aug 14, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.